BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 23516330)

  • 1. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways.
    Cupp ME; Nayak SK; Adem AS; Thomsen WJ
    J Pharmacol Exp Ther; 2013 Jun; 345(3):404-18. PubMed ID: 23516330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of β-catenin binding to parathyroid hormone (PTH) receptor inhibits PTH-stimulated ERK1/2 activation.
    Yang Y; Wang B
    Biochem Biophys Res Commun; 2015 Aug; 464(1):27-32. PubMed ID: 26047699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Arrestin-biased signaling of PTH analogs of the type 1 parathyroid hormone receptor.
    van der Lee MM; Verkaar F; Wat JW; van Offenbeek J; Timmerman M; Voorneveld L; van Lith LH; Zaman GJ
    Cell Signal; 2013 Feb; 25(2):527-38. PubMed ID: 23159578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular signal-regulated kinase activation by parathyroid hormone in distal tubule cells.
    Sneddon WB; Yang Y; Ba J; Harinstein LM; Friedman PA
    Am J Physiol Renal Physiol; 2007 Mar; 292(3):F1028-34. PubMed ID: 17107942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrestins in bone.
    Bohinc BN; Gesty-Palmer D
    Prog Mol Biol Transl Sci; 2013; 118():335-58. PubMed ID: 23764060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone receptor trafficking contributes to the activation of extracellular signal-regulated kinases but is not required for regulation of cAMP signaling.
    Syme CA; Friedman PA; Bisello A
    J Biol Chem; 2005 Mar; 280(12):11281-8. PubMed ID: 15611080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino-terminal parathyroid hormone fragment analogs containing alpha,alpha-di-alkyl amino acids at positions 1 and 3.
    Shimizu N; Dean T; Khatri A; Gardella TJ
    J Bone Miner Res; 2004 Dec; 19(12):2078-86. PubMed ID: 15537452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies.
    Esbrit P; Alcaraz MJ
    Biochem Pharmacol; 2013 May; 85(10):1417-23. PubMed ID: 23500550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G alpha q family members couple parathyroid hormone (PTH)/PTH-related peptide and calcitonin receptors to phospholipase C in COS-7 cells.
    Offermanns S; Iida-Klein A; Segre GV; Simon MI
    Mol Endocrinol; 1996 May; 10(5):566-74. PubMed ID: 8732687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
    Kondo H; Guo J; Bringhurst FR
    J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological and Pharmacological Roles of PTH and PTHrP in Bone Using Their Shared Receptor, PTH1R.
    Martin TJ; Sims NA; Seeman E
    Endocr Rev; 2021 Jul; 42(4):383-406. PubMed ID: 33564837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberoinfundibular peptide (7-39) [TIP(7-39)], a novel, selective, high-affinity antagonist for the parathyroid hormone-1 receptor with no detectable agonist activity.
    Hoare SR; Usdin TB
    J Pharmacol Exp Ther; 2000 Nov; 295(2):761-70. PubMed ID: 11046116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic AMP formation in rat bone and kidney cells is stimulated equally by parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34.
    Blind E; Raue F; Knappe V; Schroth J; Ziegler R
    Exp Clin Endocrinol; 1993; 101(3):150-5. PubMed ID: 8223983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D and dexamethasone inversely regulate parathyroid hormone-induced regulator of G protein signaling-2 expression in osteoblast-like cells.
    Hömme M; Schmitt CP; Himmele R; Hoffmann GF; Mehls O; Schaefer F
    Endocrinology; 2003 Jun; 144(6):2496-504. PubMed ID: 12746312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of parathyroid hormone (PTH)/secretin receptor chimeras differentiates the role of functional domains in the pth/ pth-related peptide (PTHrP) receptor on hormone binding and receptor activation.
    Vilardaga JP; Lin I; Nissenson RA
    Mol Endocrinol; 2001 Jul; 15(7):1186-99. PubMed ID: 11435617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of the receptor for parathyroid hormone (PTH) and PTH-related peptide by PTH in primary fetal rat osteoblasts.
    Jongen JW; Willemstein-van Hove EC; van der Meer JM; Bos MP; Jüppner H; Segre GV; Abou-Samra AB; Feyen JH; Herrmann-Erlee MP
    J Bone Miner Res; 1996 Sep; 11(9):1218-25. PubMed ID: 8864895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation.
    Gesty-Palmer D; Chen M; Reiter E; Ahn S; Nelson CD; Wang S; Eckhardt AE; Cowan CL; Spurney RF; Luttrell LM; Lefkowitz RJ
    J Biol Chem; 2006 Apr; 281(16):10856-64. PubMed ID: 16492667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of glycosylation in expression and function of the human parathyroid hormone/parathyroid hormone-related protein receptor.
    Bisello A; Greenberg Z; Behar V; Rosenblatt M; Suva LJ; Chorev M
    Biochemistry; 1996 Dec; 35(49):15890-5. PubMed ID: 8961954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human PTH2 receptor: binding and signal transduction properties of the stably expressed recombinant receptor.
    Behar V; Pines M; Nakamoto C; Greenberg Z; Bisello A; Stueckle SM; Bessalle R; Usdin TB; Chorev M; Rosenblatt M; Suva LJ
    Endocrinology; 1996 Jul; 137(7):2748-57. PubMed ID: 8770894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-selective dissociation of activation and internalization of the parathyroid hormone (PTH) receptor: conditional efficacy of PTH peptide fragments.
    Sneddon WB; Magyar CE; Willick GE; Syme CA; Galbiati F; Bisello A; Friedman PA
    Endocrinology; 2004 Jun; 145(6):2815-23. PubMed ID: 15016722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.